These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4560767)

  • 1. The immunosuppressive activity of procarbazine hydrochloride in canine renal allografts by donor pretreatment.
    Varkarakis MJ; Abramczyk J; Brede HD; Murphy GP
    J Surg Oncol; 1972; 4(3):235-47. PubMed ID: 4560767
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of procarbazine hydrochloride (natulan) and procarbazine hydrochloride and azathioprine in canine renal allografts.
    Macdonald AS; Chan CC; Falvey CF
    Transplantation; 1971 Jan; 11(1):103-4. PubMed ID: 4927302
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunosuppressive effect of procarbazine hydrochloride in canine renal allografts.
    Varkarakis MJ; Sampson D; Brede HD; Murphy GP
    Transplantation; 1972 Jan; 13(1):42-4. PubMed ID: 4550346
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of medroxyprogesterone and corticosteroids in the treatment of canine renal allografts.
    Macdonald AS; Falvey CF; Chan CC
    Can J Surg; 1972 Sep; 15(5):326-31. PubMed ID: 4560407
    [No Abstract]   [Full Text] [Related]  

  • 7. A study on the mechanism of donor pretreatment: effect of procarbazine hydrochloride and methylprednisolone in immunocompetent cells.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1981 Jul; 32(1):24-8. PubMed ID: 7022795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recipient conditioning with beagle plasma and beagle liver: prolongation of kidney-graft function without preoperative lymphocytotoxic antibody formation].
    Harder F; Floersheim GL; Jeekel J; vd Linden C; Mihatsch MJ; Rüedi T; Tondelli P
    Helv Chir Acta; 1979 May; 46(1-2):219-23. PubMed ID: 381255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood transfusions on antibody formation and canine renal allograft survival.
    Currier CB; Pierce JC
    Surg Gynecol Obstet; 1974 Aug; 139(2):241-4. PubMed ID: 4601702
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is azathioprine necessary in renal transplantation?
    Sheriff MH; Yayha T; Lee HA
    Lancet; 1978 Jan; 1(8056):118-20. PubMed ID: 87552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs.
    Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068
    [No Abstract]   [Full Text] [Related]  

  • 13. Manipulation of allograft immunogenicity by pretreatment of cadaver donors.
    Guttmann RD
    Urol Clin North Am; 1976 Oct; 3(3):475-90. PubMed ID: 790729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CANINE RENAL HOMOGRAFTS: PROLONGATION OF HOMOGRAFTS BY DELAYED ANTIMETABOLITE ADMINISTRATION.
    ZUKOSKI CF
    JAMA; 1965 Mar; 191():1017-8. PubMed ID: 14257729
    [No Abstract]   [Full Text] [Related]  

  • 15. Nature of hyperacute (accelerated second set) rejection in dog renal allografts and effects of heparin on rejection process.
    Amery AH; Pegrum GD; Risdon RA; Williams G
    Br Med J; 1973 Feb; 1(5851):455-8. PubMed ID: 4570252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of immunosuppression on the patency and structure of canine vein allografts in the venous system.
    Kojima Y; Sanada Y; Fonkalsrud EW
    Surg Gynecol Obstet; 1982 Jun; 154(6):853-7. PubMed ID: 7079928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 18. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of factors affecting the antigen structure of the donor kidney. I. Interpretation of the relationship between periodate pretreatment and the rejection phenomena of canine kidney allografts.
    Török B; Röth E; Tóth I; Deák G
    Int Urol Nephrol; 1979; 11(3):215-22. PubMed ID: 227804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of kidney allograft survival in dogs with donor pretreatment.
    Chassot PG; Beaudoin JG; Guttmann RD
    Surg Forum; 1974; 25(0):314-6. PubMed ID: 4612787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.